Rosan T A, Mesones H L, Brengio F
Acta Psiquiatr Psicol Am Lat. 1994 Dec;40(4):314-20.
This paper shows the results of associating tricyclic and MAOI antidepressants in the treatment of resistant major depression. Forty five patients from private practice with diagnosis of major depression according to DSM III R criteria, with negative response to separate tricyclic or MAOI treatment, were given both types associated. They improved without dangerous side effects.
本文展示了将三环类和单胺氧化酶抑制剂类抗抑郁药联合用于治疗难治性重度抑郁症的结果。45名来自私人诊所、根据《精神疾病诊断与统计手册》第三版修订版标准诊断为重度抑郁症、对单独使用三环类或单胺氧化酶抑制剂类药物治疗无反应的患者,接受了这两类药物的联合治疗。他们的病情得到改善,且未出现危险的副作用。